Jensen Eric D, Schroeder Tania M, Bailey Jaclyn, Gopalakrishnan Rajaram, Westendorf Jennifer J
The Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
J Bone Miner Res. 2008 Mar;23(3):361-72. doi: 10.1359/jbmr.071104.
HDAC7 associates with Runx2 and represses Runx2 transcriptional activity in a deacetylase-independent manner. HDAC7 suppression accelerates osteoblast maturation. Thus, HDAC7 is a novel Runx2 co-repressor that regulates osteoblast differentiation.
Runx2 is a key regulator of gene expression in osteoblasts and can activate or repress transcription depending on interactions with various co-factors. Based on previous observations that several histone deacetylases (HDACs) repress Runx2 activity and that HDAC inhibitors accelerate osteoblast differentiation in vitro, we hypothesized that additional HDACs may also affect Runx2 activity.
A panel of HDACs was screened for repressors of Runx2 activity. Immunofluorescence, co-immunoprecipitation, GST-pulldowns, and chromatin immunoprecipitations were used to characterize the interactions between Runx2 and HDAC7. Expression of osteoblast markers was examined in a C2C12 cell osteoblast differentiation model in which HDAC7 levels were reduced by RNAi.
Runx2 activity was repressed by HDAC7 but not by HDAC9, HDRP, HDAC10, or HDAC11. HDAC7 and Runx2 were found co-localized in nuclei and associated with Runx2-responsive promoter elements in osseous cells. A carboxy-terminal domain of Runx2 associated with multiple regions of HDAC7. Although direct interactions with Runx2 were confined to the carboxy terminus of HDAC7, this region was dispensable for repression. In contrast, the amino terminus of HDAC7 bound Runx2 indirectly and was necessary and sufficient for transcriptional repression. Treatment with HDAC inhibitors did not decrease inhibition by HDAC7, indicating that HDAC7 repressed Runx2 by deacetylation-independent mechanism(s). Suppression of HDAC7 expression in C2C12 multipotent cells by RNAi accelerated their BMP2-dependent osteoblast differentiation program. Consistent with this observation, BMP2 decreased nuclear localization of HDAC7.
These results establish HDAC7 as a regulator of Runx2's transcriptional activity and suggest that HDAC7 may be an important regulator of the timing and/or rate of osteoblast maturation.
HDAC7与Runx2结合,并以一种不依赖去乙酰化酶的方式抑制Runx2的转录活性。HDAC7的抑制作用可加速成骨细胞成熟。因此,HDAC7是一种调节成骨细胞分化的新型Runx2共抑制因子。
Runx2是成骨细胞中基因表达的关键调节因子,可根据与各种辅助因子的相互作用激活或抑制转录。基于先前的观察结果,即几种组蛋白去乙酰化酶(HDACs)抑制Runx2活性,且HDAC抑制剂在体外可加速成骨细胞分化,我们推测其他HDACs也可能影响Runx2活性。
筛选一组HDACs作为Runx2活性的抑制因子。采用免疫荧光、免疫共沉淀、GST下拉和染色质免疫沉淀技术来表征Runx2与HDAC7之间的相互作用。在通过RNAi降低HDAC7水平的C2C12细胞成骨细胞分化模型中检测成骨细胞标志物的表达。
HDAC7可抑制Runx2活性,但HDAC9、HDRP、HDAC10或HDAC11则不能。发现HDAC7和Runx2共定位于细胞核中,并与骨细胞中Runx2反应性启动子元件相关。Runx2的羧基末端结构域与HDAC7的多个区域相关。虽然与Runx2的直接相互作用仅限于HDAC7的羧基末端,但该区域对于抑制作用并非必需。相反,HDAC7的氨基末端间接结合Runx2,并且对于转录抑制是必需且充分的。用HDAC抑制剂处理并不会降低HDAC7的抑制作用,表明HDAC7通过不依赖去乙酰化的机制抑制Runx2。通过RNAi抑制C2C12多能细胞中HDAC7的表达可加速其依赖BMP2的成骨细胞分化程序。与该观察结果一致,BMP2可降低HDAC7的核定位。
这些结果确立了HDAC7作为Runx2转录活性的调节因子,并表明HDAC7可能是成骨细胞成熟时间和/或速率的重要调节因子。